Clinical Trial Update: A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

This completed Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of multiple subcutaneous injections of ABBV-257 in subjects with rheumatoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ABBV-257 (ABBV-257)

Snippet

Sponsor: AbbVie | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED